study of treatment for post stroke dementia

study of edaravone treatment for post stroke dementia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003462

Enrollment

Unknown

Registered

2013-03-10

Start date

2013-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post stroke dementia

Interventions

VD:donepezil

treatment of VD:edaravone+donepezil

MD:donepezil

treament of MD:edaravone+donepezil

AD:donepezil

treament of AD:donepezil

treament of AD:edaravone+donepezil

Eligibility

Sex/Gender

All

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50 to 80 years old; 2. post stroke dementia.

Exclusion criteria

Exclusion criteria: 1. Severe strokeincluding disturbance of consciousness, anomia, aphasia, apraxia and agraphia; 2. being treated; 3. Intracranial infection and cerebral trauma; 4. heart disease; 5. liver and kidney function damage; 6. hematological system diseases; 7. peptic ulcer; 8. psychiatric disorders; 9. epilepsia; 10. drug allergy.

Design outcomes

Primary

Measure	Time frame
Mini-Mental State Examination( MMSE);imaging detection;inflammatory factor;apolipoprotein E (ApoE);amyloid beta;tau protein;ADL;ADScog;	—

Countries

China

Contacts

Public ContactYanjiang Wang

wayaja@gmail.com+86 23 68757852

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026